Website
http://dataportal.arc.gov.au/NCGP/API/grants/LP130100826
Funding Status
Closed
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Funded Activity Summary
Utilisation of dense gas technology for the development of controlled release active pharmaceutical ingredients (API) delivery systems. The aim of this project is to develop an orally administered drug formulation for the treatment of irritable bowel syndrome and other diseases of the colon. Irritable bowel syndrome is a debilitating condition and the cost to society is similar to that of asthma. As such, the project has the potential to have a major impact on society.Funded Activity Details
Start Date: 12-2013
End Date: 06-2019
Funding Scheme: Linkage Projects
Funding Amount: $481,000.00
Funder: Australian Research Council
Research Topics
ANZSRC Field of Research (FoR)
Nanomedicine | Chemical Engineering Design | Nanotechnology | Nanobiotechnology
